Home About Clinicians Patients Investors Careers Media Contact About > Mission and Values Our Mission To improve the quality and longevity of patients’ lives by providing innovative interventional oncology solutions Our Values Compassion We put the patient first. Every time. We always treat others with respect. We place paramount importance on the safety of our people, patients and healthcare professionals. Advancement We are committed to advancing patients’ quality of life and longevity through the development of innovative solutions. We seek to continuously increase productivity and efficiency in everything we do. We have an unrelenting focus on quality. Reputation We insist on meeting and exceeding requirements for corporate, environmental and social governance. We insist on a culture of transparency and trust. We do the right thing. Every time. Empowerment We deliver on our commitments; to our patients, our clinicians, our customers, our shareholders, our suppliers and each other. We provide an environment for our colleagues to grow and develop. . . . because we CARE. Mission and Values Senior Leadership Team Who we are Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. What are SIR-Spheres® Y-90 resin microspheres? SIR-Spheres® Y-90 resin microspheres are a medical device used in Selective Internal Radiation Therapy (SIRT) for treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. To view the Technical Bulletin regarding our indication, click here. Contact or follow us Contact Us SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Terms of Use | Privacy Information W9-E-0214 Effective May 7, 2021, SIR-Spheres will have the following indication for use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. Click here to view our Technical Bulletin. Ok